Enrollment Open: CHARM2

We are currently recruiting participants for our newest CHARM study:
cfDNA in Hereditary And High-Risk Malignancies (CHARM) 2: Evaluating the Performance of a cfDNA Blood Test for Early Cancer Detection

We are actively recruiting participants from across Canada who meet the following eligibility criteria*:

1. Cancer-free for at least 3 years at the time of study enrollment:
  • Individuals with and without a personal history of cancer are eligible. At the time of study enrollment, however, individuals must be cancer free (no evidence of disease) for at least 3 years. 
2. With a pathogenic or likely pathogenic variant in one of the following genes:
  • BRCA1, BRCA2, PALB2 (Hereditary Breast and Ovarian Cancer)
  • CDH1 (Hereditary Diffuse Gastric Cancer)
  • MLH1, MSH2, MSH6, PMS2, EPCAM (Lynch Syndrome)
  • NF1 (Neurofibromatosis Type 1)
  • TP53 (Li-Fraumeni Syndrome)
3. Residing in one of the following provinces:
  • British Columbia
  • Alberta
  • Ontario
  • Quebec
  • Nova Scotia
  • Newfoundland and Labrador

Interested in participating?

If you meet the eligibility criteria above and are interested in joining the CHARM2 study, please contact us for a full eligibility review*. More information about the CHARM2 study can be found here.

We appreciate your interest!

Contact Us →